BIO praises Securities and Exchange Commission for approving proposal by the national securities exchange and FINRA for 2-year pilot program that would widen minimum quoting and trading increments for stocks of some smaller companies. Pilot program will test impact of $0.05 tick on certain small companies to spur trading activity in their stock. BIO believes that pilot will increase liquidity and capital availability necessary for emerging biotech companies to be successful on public market.